3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Psoriasis
1
Interventions
tofacitinib
1
deucravacitinib
1
abrocitinib
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Psoriasis
×
deucravacitinib
×
Clear all
NCT06281106
2025-04-02
TYPP
Centre Hospitalier Universitaire Vaudois
Phase 2/3
Terminated
2 enrolled